Triisopropylsilyl Trifluoromethanesulfonate: A Crucial Intermediate for Advanced Therapeutics
Unlock breakthroughs in cancer treatment and drug discovery with this high-purity chemical intermediate.
Get a Quote & SampleProduct Core Value
Triisopropylsilyl Trifluoromethanesulfonate
This high-purity chemical intermediate, Triisopropylsilyl Trifluoromethanesulfonate (CAS NO: 80522-42-5), is indispensable for the synthesis of potent BRAF kinase inhibitors, crucial for the therapeutic treatment of melanoma. It also plays a vital role in the synthesis of the antitumor antibiotic (+)-FR900482, marking it as a cornerstone in advanced pharmaceutical research and development.
- Discover the significance of Triisopropylsilyl Trifluoromethanesulfonate synthesis in developing next-generation cancer therapies.
- Explore how CAS 80522-42-5 chemical uses contribute to the creation of potent BRAF inhibitors for melanoma treatment.
- Understand the role of this intermediate in the synthesis of antitumor antibiotic FR900482, advancing medical frontiers.
- Learn about the key chemical properties including high purity and specific physical characteristics essential for advanced organic synthesis.
Advantages Offered by the Product
Enabling Potent BRAF Inhibitors
This chemical intermediate is pivotal in the synthesis of potent BRAF kinase inhibitors, directly impacting the therapeutic treatment of melanoma, underscoring its importance in targeted cancer therapy drug development.
Facilitating Antitumor Antibiotic Production
Its application in the synthesis of antitumor antibiotic (+)-FR900482 highlights its versatility and critical role in creating novel treatments for complex diseases, supporting specialty pharmaceutical reagents.
High Purity for Reliable Synthesis
With a purity of 97% min, this compound ensures reliable and efficient organic synthesis processes, making it a preferred choice for advanced chemical intermediates for oncology.
Key Applications
Melanoma Treatment Research
Essential for synthesizing potent BRAF kinase inhibitors used in the therapeutic treatment of melanoma, a critical area in targeted cancer therapy drug development.
Antitumor Antibiotic Synthesis
A key building block for producing the antitumor antibiotic (+)-FR900482, contributing to the discovery and development of novel pharmaceutical agents.
Advanced Organic Synthesis
Its specific chemical structure and purity make it a valuable reagent in complex organic synthesis, supporting the creation of advanced pharmaceutical building blocks for drug discovery.
Oncology Drug Development
Serves as a critical chemical intermediate for developing targeted cancer therapies, particularly those focused on inhibiting key signaling pathways like BRAF.